Julien Wipff1, Laetitia Sparsa2, Anne Lohse3, Pierre Quartier4, Andre Kahan1, Chantal Job Deslandre1. 1. Paris Descartes University, Rheumatology A department, Cochin Hospital, 75014 Paris, France. 2. Paris Descartes University, Rheumatology B department, Cochin Hospital, 75014 Paris, France; Rheumatology department, Émile-Muller Hospital, 20, avenue du Docteur-Laennec, 68100 Mulhouse, France. Electronic address: sparsal@ch-mulhouse.fr. 3. Rheumatology department, Hospital center of Belfort-Montbeliard, 90016 Belfort, France. 4. Paris Descartes University, Pediatric department, Necker Hospital, 75015 Paris, France.
Abstract
OBJECTIVE: Few studies have assessed Health-Related Quality of Life (HR-QoL) in adults following juvenile idiopathic arthritis, and none since the advent of biotherapies. The aim of our study is to assess the impact of juvenile idiopathic arthritis on quality of life in a large transitional cohort, evaluate which factors influence quality of life in juvenile idiopathic arthritis, and determine which questionnaire should be used in practice. METHODS: All consecutive juvenile idiopathic arthritis patients followed during adulthood in a transitional care program were included. Demographical, clinical and biological data were collected. The following quality of life questionnaires were administered: SF36 and EuroQoL. Age- and sex-matched controls (without rheumatic disease) were included. RESULTS: One hundred and sixty-one juvenile idiopathic arthritis (120 women and 41 men) and 76 (51/25) controls were included. Out of 161, sixty-five (40%) were considered to be in remission. Juvenile idiopathic arthritis had a large impact on the physical scales of quality of life. Pain seemed to be the most important factor affecting quality of life in cases of juvenile idiopathic arthritis. No significant difference was found between sub-types of juvenile idiopathic arthritis. CONCLUSION: In this large transitional cohort of patients at the era of biotherapies, juvenile idiopathic arthritis has a larger effect on physical than mental scale of quality of life measures. Pain was the main factor influencing quality of life. Sub-types of juvenile idiopathic arthritis do not seem to influence quality of life.
OBJECTIVE: Few studies have assessed Health-Related Quality of Life (HR-QoL) in adults following juvenile idiopathic arthritis, and none since the advent of biotherapies. The aim of our study is to assess the impact of juvenile idiopathic arthritis on quality of life in a large transitional cohort, evaluate which factors influence quality of life in juvenile idiopathic arthritis, and determine which questionnaire should be used in practice. METHODS: All consecutive juvenile idiopathic arthritispatients followed during adulthood in a transitional care program were included. Demographical, clinical and biological data were collected. The following quality of life questionnaires were administered: SF36 and EuroQoL. Age- and sex-matched controls (without rheumatic disease) were included. RESULTS: One hundred and sixty-one juvenile idiopathic arthritis (120 women and 41 men) and 76 (51/25) controls were included. Out of 161, sixty-five (40%) were considered to be in remission. Juvenile idiopathic arthritis had a large impact on the physical scales of quality of life. Pain seemed to be the most important factor affecting quality of life in cases of juvenile idiopathic arthritis. No significant difference was found between sub-types of juvenile idiopathic arthritis. CONCLUSION: In this large transitional cohort of patients at the era of biotherapies, juvenile idiopathic arthritis has a larger effect on physical than mental scale of quality of life measures. Pain was the main factor influencing quality of life. Sub-types of juvenile idiopathic arthritis do not seem to influence quality of life.
Authors: Mark Connelly; Laura E Schanberg; Stacy Ardoin; Michael Blakley; Ruy Carrasco; Peter Chira; Kristen Hayward; Maria Ibarra; Yukiko Kimura; Daniel J Kingsbury; Marisa S Klein-Gitelman; Erica Lawson; Jennifer Stinson Journal: J Pediatr Psychol Date: 2019-04-01
Authors: Ellen Dalen Arnstad; Mia Glerup; Veronika Rypdal; Suvi Peltoniemi; Anders Fasth; Susan Nielsen; Marek Zak; Kristiina Aalto; Lillemor Berntson; Ellen Nordal; Troels Herlin; Pål Richard Romundstad; Marite Rygg Journal: Pediatr Rheumatol Online J Date: 2021-03-18 Impact factor: 3.054
Authors: Ellen Dalen Arnstad; Johanne Marie Iversen; Martin Uglem; Mia Glerup; Pål Richard Romundstad; Trond Sand; Marite Rygg Journal: Arthritis Res Ther Date: 2020-11-05 Impact factor: 5.156